IP Library Granted Patent US 7,521,207
Granted Patent B2
US 7,521,207 · App. 11/377,734 · Granted Apr 21, 2009

Rhesus monkey Nur77

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,521,207
App. No.
11/377,734
Granted
Apr 21, 2009
Kind
B2
Abstract

The Macaca mulatta (rhesus monkey) Nur77 (rhNur77) nuclear receptor and the nucleic acid encoding the rhNur77 nuclear receptor are described. Further described are methods for identifying analytes that modulate expression or activity of the rhNur77 nuclear receptor. Analytes that affect Nur77 expression or activity may be used to treat or inhibit inflammatory diseases, for example, osteoarthritis and various bone, neurological, and prostrate disorders. The rhNur77 may also be used to treat various cancers, for example, prostate, ovarian, colon, lung, and gastric cancer.

Claims (25)

1. An isolated nucleic acid comprising the nucleotide sequence encoding a rhesus monkey Nur77 polypeptide having the amino acid sequence set forth in SEQ ID NO:2.

2. The isolated nucleic acid of claim 1 , wherein the nucleic acid comprises nucleotides having the nucleotide sequence set forth in SEQ ID NO: 1.

3. A vector comprising the nucleic acid of claim 1 operably linked to a heterologous promoter.

4. An isolated cell comprising the vector of claim 3 .

5. A method for producing a rhesus monkey Nur77 (rhNur77) polypeptide comprising:

(a) providing the cell of claim 4 ; and

(b) culturing the cell under conditions to produce the rhNur77 polypeptide.

6. An isolated nucleic acid comprising:

(a) nucleotides having the sequence set forth in SEQ ID NO:1 wherein nucleotide 1435 is a cytosine;

(b) nucleotides encoding a polypeptide comprising amino acids 1 to 598 of SEQ ID NO:2;

(c) nucleotides encoding a polypeptide comprising amino acids 332 to 566 of SEQ ID NO:2 which retains the function of the ligand binding domain (LBD) of Nur77;

(d) nucleotides encoding a polypeptide comprising amino acids having the sequence set forth in SEQ ID NO:2 wherein amino acid 479 is a leucine.

7. A vector comprising the nucleic acid of claim 6 operably linked to a heterologous promoter.

8. An isolated cell comprising the vector of claim 7 .

9. A method for producing a rhesus monkey Nur77 (rhNur77) polypeptide comprising:

(a) providing the cell of claim 8 ; and

(b) culturing the cell under conditions to produce the rhNur77 polypeptide.

10. An isolated nucleic acid consisting of:

(a) nucleotides 997 to 1698 of SEQ ID NO:1; or

(b) nucleotides 800 to 996 of SEQ ID NO:1.

11. A vector comprising the nucleic acid of claim 10 operably linked to a heterologous promoter.

12. A cell comprising the vector of claim 11 .

13. An isolated method for producing a rhesus monkey Nur77 (rhNur77) polypeptide comprising:

(a) providing the cell of claim 12 ; and

(b) culturing the cell under conditions to produce the rhNur77 polypeptide.

Assignments (3)
CHANGE OF NAME Recorded Jan 29, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023870/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2009
From: GAMBONE, CARLO J.; SCHMIDT, AZRIEL
To: MERCK & CO., INC.
Reel/Frame 022499/0905 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2007
From: GAMBONE, CARLO J.; SCHMIDT, AZRIEL
To: MERCK & CO., INC.
Reel/Frame 020040/0867 →